AVE2268
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVE2268, covering 2009-02-09 to 2009-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment [Phase 2]